Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20141
20171
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion1
Biogen1
Celgene1
Emerald Health Pharmaceuticals1
GlaxoSmithKline1
Innate Immunotherapeutics1
ModernaTX, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis7
Autoimmune Diseases of the Nervous System1
Multiple Sclerosis, Chronic Progressive1
Multiple Sclerosis, Relapsing-Remitting1
Muscle Spasticity1
Nervous System Diseases1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.